NeoGenomics, Inc. (NEO)
9.44
+0.18
(+1.94%)
USD |
NASDAQ |
May 01, 16:00
9.62
+0.18
(+1.91%)
After-Hours: 20:00
NeoGenomics EPS Diluted (Quarterly) : -0.1324 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| UnitedHealth Group, Inc. | 6.901 |
| ADMA Biologics, Inc. | 0.2025 |
| Amphastar Pharmaceuticals, Inc. | 0.518 |
| Krystal Biotech, Inc. | 1.699 |
| Monte Rosa Therapeutics, Inc. | -0.7039 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.11M |
| Revenue (Quarterly) | 186.67M |
| Total Expenses (Quarterly) | 203.78M |
| Enterprise Value | 1.492B |
| Gross Profit Margin (Quarterly) | 41.70% |
| Profit Margin (Quarterly) | -9.16% |
| Earnings Yield | -8.19% |
| Normalized Earnings Yield | -6.172 |